Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPublic Policy Regulatory News (PPHC)

Share Price Information for Public Policy (PPHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 125.50
Bid: 123.00
Ask: 128.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.065%)
Open: 125.50
High: 125.50
Low: 125.50
Prev. Close: 125.50
PPHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

19 Jun 2023 07:00

RNS Number : 0632D
Public Policy Holding Company, Inc.
19 June 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

Public Policy Holding Company, Inc.

 

("PPHC", the "Group" or the "Company")

 

Business Update

 

 Public Policy Holding Company, Inc., the government relations and public affairs group providing clients with a fully integrated and comprehensive range of services, is pleased to provide an update on its M&A pipeline, current trading and employee shareholding.

 

M&A pipeline and strategy

 

Following the successful completion of the earnings accretive acquisitions of KP Public Affairs in October 2022 and MultiState Associates in March 2023, the Group has seen a marked acceleration in its pipeline of M&A opportunities and looks forward to updating shareholders in the second half of the year to the extent these current opportunities crystallise.

 

The Group's stated M&A strategy includes its desire to add certain complementary specialisations to its portfolio, as well as to expand its footprint both in the United States and internationally into the EU and UK.

 

The Group continues to adopt a disciplined approach to its M&A strategy with a focus on:

 

· Best in class ethical and compliance standards in place at target companies;

· Resultant market share and diversification benefits;

· Attractive financial profiles;

· Long term revenue synergy potential;

· Sufficient level of scale and institutionalisation; and

· Negotiating deal structures that align the owners of the target with the Group in the long term and deliver shareholder value.

 

Current trading

 

The Group reiterates existing guidance for FY23 and expects organic growth for the year to be 5% to 10%. Overall, management expects revenue growth for the year of between 20% and 30%, factoring in the incremental contribution from KP Public Affairs and Multistate Associates.

 

The Group continues to manage the business such that the Underlying EBITDA margin is expected to be between 25% and 30% on a full year basis. The Group saw moderated growth in Q1 primarily as a result of delays in U.S. Congress formation, however Q2 to date has been strong. H1 margins are therefore anticipated to be marginally below 25%, which is expected to reverse through H2. Management retains immediate and long-term confidence in the Group's growth and margin prospects.

 

Dividend and cash

 

Following the payment of the FY22 final dividend of $10.6m on 2 June 2023, the Group had gross cash on its balance sheet of $4m and $13m debt outstanding under its $17m credit facility with Bank of America, N.A., resulting in a net debt position of $9m. The Group continues to accumulate cash on a monthly basis and the next dividend is due to be paid in October 2023 following the announcement of the interim results for the six months ending 30 June 2023.

 

The Group views its current dividend policy and the payment of semi-annual dividends as a key tool in the alignment of its internal (employee) shareholders and external shareholders and as validation of the strong free cash flow generation of the business.

 

The Group expects to announce its interim results for the six months ending 30 June 2023 in September 2023.

 

Employee Shareholding

 

As at the date of the Group's IPO on 16 December 2021, an aggregate of 80,354,500 shares (74.2% of total issued shares at admission) were held by employee shareholders and subject to a five-year vesting schedule with vesting occurring in equal instalments on each of the first five anniversaries from admission. Following the first vesting on 16 December 2022, no employee-owned shares have been sold and those employees are now unable to sell due to the current blackout period until after the release of the Group's interim results. Management views this stable employee shareholding situation as a testament to the belief the Group's employees hold in the Group's future prospects.

 

 

 

Enquiries

Public Policy Holding Company Inc.

Stewart Hall, CEO

Bill Chess, CFO

Thomas Gensemer, Chief Strategy Officer

Roel Smits, Deputy CFO

 

+1 (202) 688 0020

 

Stifel (Nominated Adviser & Broker)

Fred Walsh, Tom Marsh

 

+44 (0) 20 7710 7600

Buchanan Communications (Media Enquiries)

Chris Lane, Toto Berger

+44 (0) 20 7466 5000 pphc@buchanan.uk.com

 

About PPHC

Incorporated in 2014, PPHC is a US-based government relations and public affairs group providing clients with a fully integrated and comprehensive range of services including government and public relations, research and digital advocacy campaigns. Retained by over two-thirds of its 1000+ clients, including corporates, trade associations and non-governmental organisations, the Group is active in all major sectors of the U.S. economy, including healthcare and pharmaceuticals, financial services, energy, technology, telecoms and transportation. PPHC's services support clients to enhance and defend their reputations, advance policy goals, manage regulatory risk, and engage with US federal and state-level policy makers, stakeholders, media and the public.

 

PPHC operates a holding company structure and currently has seven operating entities comprising Crossroads Strategies, Forbes Tate Partners, Seven Letter, O'Neill & Associates, Alpine Group Partners, KP Public Affairs and MultiState Associates. Operating in the strategic communications market, the Group has a strong track record of organic and acquisitive growth, the latter focused on enhancing its capabilities and to establish new verticals, either within new geographies or new related offerings.

 

For more information, see www.pphcompany.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFAFMMEDSEDM
12
Date   Source Headline
31st May 202410:49 amRNSRestricted Shares Issuance
30th May 20245:01 pmRNSDirector Transfer of Shareholding
30th May 20247:00 amRNSAppointment of Joint Broker
21st May 20247:00 amRNSRestricted Shares Issuance & Director Dealing
9th May 20244:14 pmRNSResult of AGM
8th May 20247:00 amRNSInvestor Webinar
2nd May 20247:00 amRNSIssue of shares and total voting rights
1st May 20247:05 amRNSAcquisition of Lucas Public Affairs
1st May 20247:00 amRNSSupplemental Credit Facility
24th Apr 20247:00 amRNSNotice of AGM
18th Apr 20244:41 pmRNSPosting of Annual Report
5th Apr 20241:01 pmRNSDirector/PDMR Share Purchases
4th Apr 20247:00 amRNSPPHC: top position in Bloomberg Govt 2023 Report
20th Mar 202410:36 amRNSIssue of shares and total voting rights
20th Mar 202410:22 amRNSPCA Share Purchase
13th Mar 20247:00 amRNSUnaudited Preliminary Results
5th Mar 20247:00 amRNSNotice of Results & Presentation via IMC
1st Feb 202412:00 pmRNSIssue of shares and total voting rights
24th Jan 20247:00 amRNS2023 Lobbying Disclosure Act revenue rankings
15th Dec 20237:00 amRNSBoard Appointment
4th Dec 20237:00 amRNSRestricted Shares Issuance
30th Nov 20237:00 amRNSTwo Agencies included in 2024 Agency Elite Top 100
17th Nov 20231:45 pmRNSNotification of Major Holdings
15th Nov 20237:00 amRNSDirector/PDMR Share Purchase
13th Nov 202312:00 pmRNSPPHC Launches Concordant Advisory
8th Nov 20237:00 amRNSDirector/PDMR Share Purchase
1st Nov 20239:22 amRNSDirector/PDMR Share Purchases
1st Nov 20237:00 amRNSRestricted Shares Issuance and PDMR Dealing
31st Oct 20237:00 amRNSRemoval of Reg S Restrictions
30th Oct 20237:00 amRNSDirector/PDMR Share Purchases
26th Oct 20237:00 amRNSPPHC: #1 in LDA revenue rankings
6th Oct 20237:00 amRNSIssue of Awards Under Omnibus Plan
28th Sep 20237:00 amRNSRetail Investor Presentation
20th Sep 20234:22 pmRNSDirector/PDMR Dealing
14th Sep 20237:00 amRNSPresentation via Investor Meet Company
13th Sep 20237:01 amRNSBoard Appointment & Removal of Reg S restrictions
13th Sep 20237:00 amRNSInterim Results
2nd Aug 20237:00 amRNSLeading the Q2 Lobbying Disclosure Act rankings
26th Jul 20237:00 amRNSPPHC leader recognised as Lobbyist of the Year
3rd Jul 20237:00 amRNSChief Financial Officer Succession
27th Jun 202310:00 amRNSNotification of Major Holdings
27th Jun 20237:00 amRNSPPHC: top position in Bloomberg Govt 2022 Report
26th Jun 20237:00 amRNSMello Investor Presentation
23rd Jun 20239:02 amRNSIssue of shares and total voting rights
19th Jun 20237:00 amRNSBusiness Update
24th May 20237:00 amRNSIssue of Awards Under Omnibus Plan
18th May 20235:25 pmRNSResult of AGM
26th Apr 20237:00 amRNSDirector/PDMR Dealing
26th Apr 20237:00 amRNSInvestor Presentation / Trading Platforms
20th Apr 202310:30 amRNSNotice of AGM and posting of Annual Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.